UTAH MEDICAL PRODUCTS, INC. Proceeds and Excess Tax Benefit from Share-based Compensation
UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Proceeds and Excess Tax Benefit from Share-based Compensation of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-16.
Discontinued › Notes › Compensation Related Costs
us-gaap:ProceedsAndExcessTaxBenefitFromSharebasedCompensation · last filed 2020-03-16
- UTAH MEDICAL PRODUCTS, INC. proceeds and excess tax benefit from share-based compensation for fiscal 2019 was $0.00.
- UTAH MEDICAL PRODUCTS, INC. proceeds and excess tax benefit from share-based compensation for fiscal 2018 was $0.00.
- UTAH MEDICAL PRODUCTS, INC. proceeds and excess tax benefit from share-based compensation for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- UTAH MEDICAL PRODUCTS, INC. proceeds and excess tax benefit from share-based compensation for fiscal 2016 was $50.00K.
| Period end | Proceeds and Excess Tax Benefit from Share-based Compensation 12 month |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-16 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-16 |
| 2017-12-31 | $0.00 10-K · filed 2020-03-16 |
| 2016-12-31 | $50.00K 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |